161233-97-2Relevant articles and documents
Method for converting halogenopyridinecarboxylic acid into cyanopyridinecarboxylic acid
-
Paragraph 0047-0050, (2019/07/04)
The invention provides a method for converting halogenopyridinecarboxylic acid into cyanopyridinecarboxylic acid. The method is characterized in that the halogenopyridinecarboxylic acid reacts with acyanidation reagent to form the cyanopyridinecarboxylic acid. The preparation method makes the halogenopyridinecarboxylic acid directly converted into the cyanopyridinecarboxylic acid in one step, sothe method has the advantages of omission of esterification and hydrolysis steps, simplification of synthesis steps, shortening of the reaction process, manpower saving, productivity increase, reduction of three wastes, suitableness for industrial production, and broad application prospect.
COMPOUNDS AND METHODS for the inhibition of HDAC
-
, (2015/11/24)
Disclosed are compounds having the formula: wherein X1, X2, X3, R1, R2, R3, R4, Y, A, Z, L and n are as defined herein, and methods of making and using the same.
NON-PEPTIDYL, POTENT, AND SELECTIVE MU OPIOID RECEPTOR ANTAGONISTS
-
Page/Page column 62, (2010/08/08)
Selective, non-peptide antagonists of the ma opioid receptor { MOR) and methods of their use are provided. The antagonists may be used, for example, to identify MOR agonists in competitive binding assays, and to treat conditions related to addiction in which MOR is involved, e.g. heroin, prescription drug and alcohol addiction.